Cargando…

Humanized mice as a useful model to study HIV-1 induced immune activation, its mechanisms and potential therapeutic approaches

Detalles Bibliográficos
Autores principales:	Singh, Maneesh, Singh, Pratibha, Vaira, Dolores, Tasken, Kjetil, Rahmouni, Souad, Moutschen, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236953/ http://dx.doi.org/10.1186/1742-4690-8-S2-P62

Ejemplares similares

An Improved Protocol for Efficient Engraftment in NOD/LTSZ-SCIDIL-2Rγ(NULL) Mice Allows HIV Replication and Development of Anti-HIV Immune Responses
por: Singh, Maneesh, et al.
Publicado: (2012)

Downregulation of CD94/NKG2A inhibitory receptors on CD8(+ )T cells in HIV infection is more pronounced in subjects with detected viral load than in their aviraemic counterparts
por: Zeddou, Mustapha, et al.
Publicado: (2007)

Impact of coronavirus pandemic and containment measures on HIV diagnosis
por: Darcis, Gilles, et al.
Publicado: (2020)

Dusp3 deletion in mice promotes experimental lung tumour metastasis in a macrophage dependent manner
por: Vandereyken, Maud, et al.
Publicado: (2017)

Therapeutic implications of nanoencapsulated M. avium / HIV drugs against experimental tuberculosis in mice
por: Grewal, Tapinder, et al.
Publicado: (2012)

Exploring the link between innate immune activation and thymic function by measuring sCD14 and TRECs in HIV patients living in Belgium
por: De Voeght, Adrien, et al.
Publicado: (2017)

Evaluation of the therapeutic educational consultations of patients infected by the Human Immunodeficiency Virus (HIV)
por: Grangé, Jennifer, et al.
Publicado: (2010)

Identification of SFPQ as novel interacting partner of HIV-1 Integrase and its functional characterization
por: Sur, Souvik, et al.
Publicado: (2012)

What is the correct therapeutic approach in patients with advanced HIV infection associated with ≥ 3 AIDS defining illness?
por: Cozma, Alina, et al.
Publicado: (2013)

Potent cellular immune responses after therapeutic immunization of HIV-positive patients with the PENNVAX®-B DNA vaccine in a Phase I Trial
por: Tebas, P, et al.
Publicado: (2012)

Assessment of T cell immune responses towards HIV-1 epitopes designed by reverse immunogenetic approach: proof-of-concept in HIV+ Cameroonian children
por: Nemes, E, et al.
Publicado: (2012)

Immunization strategies to elicit mucosal immune response of HIV
por: Shi, Yinghui
Publicado: (2006)

CCL28 induces mucosal homing of HIV-1-specific IgA-secreting plasma cells in mice immunized with HIV-1 Virus-like Particles
por: Rainone, V, et al.
Publicado: (2012)

P-022: THERAPEUTIC EFFECTS OF GBT1118 ON SKELETAL MUSCLE ENERGETICS AND FUNCTION IN SICKLE CELL MICE
por: C., MICHEL, et al.
Publicado: (2022)

Pilot trial of oral therapeutic HIV vaccine, V-1 Immunitor, on HIV and HIV/HCV patients in Russia
por: Bourinbaiar, Aldar, et al.
Publicado: (2010)

In-silico designing of acyclic nucleoside phosphonates and their anti-HIV potential
por: Yadav, Dipti, et al.
Publicado: (2012)

Novel acyclic nucleoside analogues as inhibitors of HIV-1 RT
por: Singh, Anuradha, et al.
Publicado: (2012)

P03-02. SCID-hu mice generate HIV specific human immune responses after gp96 vaccination
por: Gonzalez, LE, et al.
Publicado: (2009)

P17-17. Newborn mice vaccination with rBCG:HIVA + MVA:HIVA enhances HIV-1-specific immune responses. Influence of age and immunization routes
por: Saubi, N, et al.
Publicado: (2009)

CN54gp140: product characteristics, peclinical and clinical use - recombinant glycoprotein for HIV immunization
por: Katinger, D, et al.
Publicado: (2012)

Next generation of antiretroviral agents targeting the RNA binding site of the HIV-1 cellular cofactor DDX3: an innovative therapeutic approach
por: Maga, Giovanni, et al.
Publicado: (2012)

Leukocyte extract reduces HIV replication and modulates cellular factors involved in HIV infection: therapeutic meant
por: Fernandez-Ortega, C, et al.
Publicado: (2010)

The innate immune system as a therapeutic target in arthritis
por: Corr, M, et al.
Publicado: (2003)

Cross talks between the immune and lymphatic endothelial cells regulate inflammatory lymph node lymphangiogenesis: defining a new therapeutic approach
por: Elhadad, Sonia
Publicado: (2013)

Homology of HIV-1 Indian subtype C tat gene with other subtypes correlates with the induction of potent cross clade immune responses following immunization with HIV-1 Indian subtype C mutated and codon optimized tat DNA/MVA vaccine in mice
por: Qureshi, Huma, et al.
Publicado: (2006)

Incidence of bacteremia at the time of ICU admission and its impact on outcome
por: Juneja, D, et al.
Publicado: (2010)

P04-21. Different human serum antibody profiles elicited by three candidate HIV vaccines using different immunization approaches
por: Vaine, M, et al.
Publicado: (2009)

Early immune events during acute HIV infection
por: Slike, BM, et al.
Publicado: (2012)

Anti-HIV and immune modulating activities of IND02
por: Biedma, ME, et al.
Publicado: (2012)

Plasma cytokine levels and HIV-specific immune responses during acute/early HIV infection
por: Turk, G, et al.
Publicado: (2012)

Stimulation of antiviral cellular immune responses by therapeutic vaccination of HIV-1-infected patients with dendritic cells transfected with gag, tat, rev and nef mRNA
por: Van Gulck, Ellen, et al.
Publicado: (2011)

P11-21. Induction of persistent mucosal humoral and cellular responses following immunization of mice with HIV-1 envelope protein in inulin-derived adjuvants
por: Cristillo, AD, et al.
Publicado: (2009)

An analysis of non response in HIV testing in India: evidences from National Family Health Survey-3
por: Singh, Shri Kant
Publicado: (2010)

Optimal timing for initiation of antiretroviral therapy: a prospective study on treatment naive HIV patients
por: Chakravarty, Jaya, et al.
Publicado: (2012)

Group psychotherapy for HIV patients. A different approach
por: Battuello, Michele, et al.
Publicado: (2012)

Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C
por: Gómez, C, et al.
Publicado: (2012)

Design and development of a new lentiviral based anti-HIV therapeutic vaccine
por: Rodriguez, M, et al.
Publicado: (2012)

Socio-epidemiological and therapeutic profile of patients infected by HIV in 2011 at Tunis (Tunisia)
por: Mrabet, A, et al.
Publicado: (2014)

Immunizations in children exposed perinatally to HIV – from theory to practice
por: Vlad, Delia Adelina, et al.
Publicado: (2014)

P19-53 LB. Priming with recombinant BCG expressing HIV-1 Gag or RT and boosting with recombinant MVA induces an effective immune response in mice
por: Stutz, H, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_bud757kcgr4f11jtppk103kkph